Hypoplastic Left Heart Syndrome clinical trials at UCLA
1 research study open to eligible people
open to eligible people ages up to 15 months
The purpose of this initiative is to improve care and outcomes for infants with HLHS by expanding the NPC-QIC national registry to gather clinical care process, outcome, and developmental data on infants with HLHS between diagnosis and 12 months of age, by improving the use of standards into everyday practice across pediatric cardiology centers, and by engaging parents as partners in the process.
Los Angeles, California and other locations
Our lead scientists for Hypoplastic Left Heart Syndrome research studies include Nancy Halnon, MD.